What does your China regulatory strategy look like?
Category Archives: Uncategorized
Internal Regulatory Intelligence
Internal regulatory data and intelligence is an often forgotten, yet critical source of information. Every organisation’s electronic files provide a rich source of data for strategic registration planning and policy creation.
Combination Products: MDR and Brexit
LinkedIn identifies 162 followers of #combinationproducts whereas the values for followers of #medicaldevice and #pharmaceuticals are 42 thousand and >1 million respectively.
BLOG Intelligence
Instem provides advanced and best-in-class IT solutions & services to the global life sciences community to improve the productivity of their processes in the discovery and development of new drugs (human and veterinary), medical devices, invitro diagnostics, therapies and products. Instem delivers these software solutions and services across the entire lifecycle of product development, from …
UKCA for Medical Devices
I recently attended a brilliantly presented BSI webinar entitled: “UKCA for Medical devices and IVDs, are you ready?” which provided additional insight and confirmation of the UKCA conformity assessment process. I also propose a heartfelt thank you to Dr. Jayanth Katta for taking his time to provide the medical device and IVD industries with guidance. …
Brexit for Medical Devices
As of 23.00 on 31st December 2020 the United Kingdom officially (and finally) withdrew as a member of the European Union (EU). Firstly, a geography lesson: the sovereign nation commonly known as the United Kingdom consists of the island of Great Britain (England, Scotland and Wales) and the north east part of the island of …
Beautification regulated as medical devices: MDR Annex XVI
Devices without a medical purpose are excluded from the scope of the Medical Device and Active Implantable Medical Device Directives, however a group of such products are now regulated in the Medical Device Regulation 2017/745 due for application on 26 May 2021. The rationale behind their inclusion is based upon potential unreasonable risks these device types may impart upon use. The legislation applies to these products regardless of whether the point of use is at home by the end consumer or in a healthcare professional setting.
Yay or Nay: Comments Requested on US EUA Policies
The United States Department of Health and Human Services (HHS) is considering making permanent and/or keeping as temporary the regulatory standards and amendments promulgated in response to the COVID–19 crisis, issued in order to improve early access to care and reduce costs.
Taiwan UDI Draft Guideline – Highlights
On 05 November 2020, the TFDA published a new draft guidance document for public consultation. The guidance document, “Requirements for the Single Identification Code to be Published on the Labels of Medical Devices”.
China UDI:Medical Devices
On 10 August 2020 the NMPA launched Unique Device Identification (UDI) Database on its website.
